Cue Biopharma (CUE) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to 0.42.
- Cue Biopharma's Equity Ratio fell 2605.37% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year decrease of 2605.37%. This contributed to the annual value of 0.54 for FY2024, which is 980.81% down from last year.
- Cue Biopharma's Equity Ratio amounted to 0.42 in Q3 2025, which was down 2605.37% from 0.45 recorded in Q2 2025.
- Cue Biopharma's Equity Ratio's 5-year high stood at 0.81 during Q2 2021, with a 5-year trough of 0.3 in Q1 2025.
- Its 5-year average for Equity Ratio is 0.62, with a median of 0.63 in 2023.
- Its Equity Ratio has fluctuated over the past 5 years, first surged by 528.16% in 2021, then plummeted by 4689.37% in 2025.
- Cue Biopharma's Equity Ratio (Quarter) stood at 0.79 in 2021, then decreased by 8.37% to 0.72 in 2022, then dropped by 16.24% to 0.6 in 2023, then fell by 9.81% to 0.54 in 2024, then decreased by 23.0% to 0.42 in 2025.
- Its last three reported values are 0.42 in Q3 2025, 0.45 for Q2 2025, and 0.3 during Q1 2025.